Skip to content

Michael Rosman

NPI 1710335773ActiveIndividual· Internal Medicine, Gastroenterology· New York, NY

Internal Medicine, Gastroenterology in New York, New York, licensed in NY, with an NPI issued in June 2016. Part D covered 19 prescriptions written in 2024, 84% of them generic. Janssen Biotech, Inc. was the largest of 21 companies reporting payments in 2025, $3,839 in all, mostly food and beverage.

Overview

NPI1710335773
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedJun 1, 2016
Last updated in NPPESJul 8, 2024
Certified by providerJul 8, 2024

Specialties and licenses

TaxonomyCodeLicenseState
Internal Medicine, Gastroenterology Primary207RG0100X298272NY

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Practitioner - Gastroenterology (NY)

Part D prescriptions in 2024

Prescriptions (claims)19 · 26 30-day fills
Total drug cost$6,883
Generic share84% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$3,839 · 213 payments from 21 companies
  • 2024$2,734 · 132 payments from 17 companies

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$3,839 · 213 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other gastroenterologists in New York

All 640 gastroenterologists in New York · All gastroenterologists in New York